1. Effects of Micronutrients or Conditional Amino Acids on COVID-19-Related Outcomes: An Evidence Analysis Center Scoping Review
- Author
-
Lisa Moloney, Feon W. Cheng, Mary Rozga, and Deepa Handu
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Medical Nutrition Therapy ,MEDLINE ,030209 endocrinology & metabolism ,Context (language use) ,Enteral administration ,Conditional Amino Acids ,Article ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Medical nutrition therapy ,Micronutrients ,Amino Acids ,Intensive care medicine ,030109 nutrition & dietetics ,Nutrition and Dietetics ,SARS-CoV-2 ,business.industry ,COVID-19 ,General Medicine ,medicine.disease ,Micronutrient ,Ascorbic acid ,COVID-19 Drug Treatment ,Pneumonia ,Treatment Outcome ,Systematic review ,Nutrition Therapy ,Nutrition Support ,business ,Food Science - Abstract
Recent narrative reviews have described the potential efficacy of providing individuals infected with coronavirus disease 2019 (COVID-19) with additional micronutrients to reduce disease severity. Although there are compelling reasons why providing additional micronutrients or conditional amino acids may affect COVID-19-related outcomes, evidence is lacking. The objective of this scoping review is to explore and describe the literature examining the effect of providing additional micronutrients or conditional amino acids (glutamine, arginine) in adults with conditions or infections similar to COVID-19 infection on COVID-19-related health outcomes. A literature search of the MEDLINE database and hand search of Cochrane Database of systematic reviews retrieved 1,423 unique studies, and 8 studies were included in this scoping review. Four studies examined a target population with ventilator-related pneumonia and acute respiratory distress syndrome, and the other 4 studies included patients who were at risk for ventilator-associated pneumonia. Interventions included intravenous ascorbic acid, intramuscular cholecalciferol, enteral and intramuscular vitamin E, enteral zinc sulfate, and oral and parenteral glutamine. In 6 of the 8 included studies, baseline status of the nutrient of interest was not reported and, thus, it is uncertain how outcomes may vary in the context of nutrient deficiency or insufficiency compared with sufficiency. In the absence of direct evidence examining efficacy of providing additional micronutrients or conditional amino acids to standard care, registered dietitian nutritionists must rely on clinical expertise and indirect evidence to guide medical nutrition therapy for patients infected with COVID-19.
- Published
- 2021
- Full Text
- View/download PDF